This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

CORRECTING And REPLACING TriPoint Global Research Publishes Research Report On IGI, Laboratories, Inc.

Please replace the release with the following corrected version due to multiple revisions.

The corrected release reads:


TriPoint Global Research publishes Research Report on IGI, Laboratories, Inc. by Senior Analysts Richard W West, CFA and Sherry Grisewood, CFA
  • Industry: Pharmaceuticals & Biotechnology
  • Current Rating: Market Perform
  • Rating Assigned: 6/13/2011
  • Analyst: Richard W West, CFA and Sherry Grisewood, CFA

A 23-page Research Report is available for download at, as well as other leading financial portals, that include Reuters, Capital IQ and Research Direct on Bloomberg terminals by entering TRPN.

About IGI, Laboratories, Inc. (Amex - IG)

IGI, Laboratories, Inc. is a topical pharmaceuticals and OTC products manufacturer primarily engaged in the production and packaging of formulations and agents used in pharmaceuticals, cosmetics, and consumer skin care products. IGI’s expertise lies in the development, formulation, turnkey manufacturing, filling and packaging of topical semi-solid, suspension and liquid products, many of which incorporate novel encapsulation and delivery technologies.

About TriPoint Global Research, LLC:

TriPoint Global Research, LLC is an independent investment research firm. Its senior analysts are primarily CFAs, and have expertise in many industries. A TriPoint Global Research, LLC research report or note is not intended as an offering or a solicitation of an offer to buy or sell the securities mentioned or discussed. Neither the firm, its principals nor the assigned analysts own or trade shares of any company covered. The firm does not accept any equity compensation. TriPoint Global Research, LLC received $17,000 from an individual investor for one research report.

Copyright Business Wire 2010

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%
TSLA $240.76 0.00%
YHOO $36.60 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs